Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Toulemonde

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1988
[Treatment of acute pulmonary embolism with a low molecular weight heparin by the intravenous route. Study of the optimal dosage]L Quilliet, B Charbonnier, B Delahousse, et al.
Thrombosis Research|May 15, 1988
Is there an optimal therapeutical range for low molecular weight heparin? An experimental studyC Doutremepuich, J L Gestreau, F Doutremepuich, et al.
Seminars in Thrombosis and Hemostasis|July 1, 1985
Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY 216)J Leroy, M H Leclerc, B Delahousse, et al.
Thrombosis Research|May 1, 1983
Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosisE G Vairel, H Bouty-Boye, F Toulemonde, et al.
Thrombosis Research|October 15, 1987
What is the best plasmatic activity which could be correlated with the antithrombotic effect of heparin and a low molecular weight heparin fragment?C Doutremepuich, T Castrioto, O De Seze, et al.
Haemostasis|January 1, 1983
Experimental venous thrombosis in rats treated with heparin and a low molecular weight heparin fractionC Doutremepuich, J L Gestreau, M O Maury, et al.
Annales Pharmaceutiques Francaises|January 1, 1985
[Histologic study of venous thrombosis induced in the rat]C Doutremepuich, M C Kuttler, F Bousquet, et al.
Pathologie-Biologie|January 1, 1984
[Duodenal absorption of a low molecular weight heparin in rabbits]C Doutremépuich, A Masse, C Oca, et al.
Thrombosis Research|August 1, 1988
Changes in plasma fibrin degradation products as a marker of thrombus evolution in patients with deep vein thrombosisM Mirshahi, C Soria, J Soria, et al.
Haemostasis|January 1, 1987
Treatment of deep venous thrombosis with a very low molecular weight heparin fragment (CY 222)G Janvier, S Winnock, G Dugrais, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1988
[Treatment of acute pulmonary embolism with a low molecular weight heparin by the intravenous route. Study of the optimal dosage]L Quilliet, B Charbonnier, B Delahousse, et al.
Thrombosis Research|May 15, 1988
Is there an optimal therapeutical range for low molecular weight heparin? An experimental studyC Doutremepuich, J L Gestreau, F Doutremepuich, et al.
Seminars in Thrombosis and Hemostasis|July 1, 1985
Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY 216)J Leroy, M H Leclerc, B Delahousse, et al.
Thrombosis Research|May 1, 1983
Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosisE G Vairel, H Bouty-Boye, F Toulemonde, et al.
Thrombosis Research|October 15, 1987
What is the best plasmatic activity which could be correlated with the antithrombotic effect of heparin and a low molecular weight heparin fragment?C Doutremepuich, T Castrioto, O De Seze, et al.
Haemostasis|January 1, 1983
Experimental venous thrombosis in rats treated with heparin and a low molecular weight heparin fractionC Doutremepuich, J L Gestreau, M O Maury, et al.
Annales Pharmaceutiques Francaises|January 1, 1985
[Histologic study of venous thrombosis induced in the rat]C Doutremepuich, M C Kuttler, F Bousquet, et al.
Pathologie-Biologie|January 1, 1984
[Duodenal absorption of a low molecular weight heparin in rabbits]C Doutremépuich, A Masse, C Oca, et al.
Thrombosis Research|August 1, 1988
Changes in plasma fibrin degradation products as a marker of thrombus evolution in patients with deep vein thrombosisM Mirshahi, C Soria, J Soria, et al.
Haemostasis|January 1, 1987
Treatment of deep venous thrombosis with a very low molecular weight heparin fragment (CY 222)G Janvier, S Winnock, G Dugrais, et al.
Pageof 7